Palace Resorts Starts Green Foundation In MexicoMi

first_imgPalace Resorts Starts Green Foundation In MexicoMiami, Florida – Reported by Elite Traveler, the Private Jet Lifestyle MagazinePalace Resorts – the company that surpasses the traditional definition of all-inclusive with the very best five-star service and amenities – is the industry leader in eco-friendly hospitality initiatives adhering to the stringent guidelines for environmental sustainability set by the Earthcheck program, MARTI & GEO certifications. Palace Resorts efforts are supported by the Palace Resorts Foundation which promotes sustainable life for the native environment and its inhabitants through the Ecological Sustainability Committee, which was developed to assist the local areas in the destinations where Palace Resorts are located.The Palace Resorts Foundation’s Environmental Committee provides tools to balance the development of Palace Resorts business with the environmental welfare of Mexico’s natural resources and its native ecological inhabitants. Ecological sustainability starts with the resort initiatives that recycle more than 124 tons of paper and plastic each year, resulting in more than 2,121 trees saved. In addition, all furniture removed from resort properties is reused by selling it for a small fee to those in need, and the profits benefit the Palace Foundation and its three committees.Employees and guests are encouraged to contribute to ecological practices through bins for recyclable and organic goods, monitoring the boiler and furnace emissions into the atmosphere, installing systems for measurement and analysis in each drainage well, and providing “ecological tent cards” in all guestrooms to minimize water and energy consumption. Additionally, Vallarta Palace, Beach Palace, Cancun Palace, Sun Palace and Cozumel Palace are equipped with an energy saving light system, which requires the room key to be inserted into a special slot upon entering to activate in-room lighting. When the key is removed upon leaving the room, all lights are turned off, saving a substantial amount of energy while guests are out enjoying the rest of the resort.Palace Resorts also safeguards native leatherback and loggerhead sea turtles in Cancun and Riviera Maya. Through the Palace Turtle Conservation Camps at Moon Palace Golf & Spa Resort, Cancun Palace, Sun Palace, Beach Palace Wyndham Grand Resort and Xpu-Ha Palace Wyndham Resort, scientists and specialists cares for turtle eggs until they hatch. Since it opened, the Camp has helped save more than 140,000 offspring of this endangered species. Palace Resort guests can get involved in this project by helping the scientists release hatched turtles into the Caribbean Sea.The brand’s green efforts through the Palace Foundation have been internationally recognized as leading the hospitality industry by some of the top conservation programs and certifications. The standard for sustainable tourism has been raised by Palace Resorts as the chain boldly became the first new group member globally to join the EarthCheck Program, the environmental sustainability program that’s raising the benchmark for certification. Through EarthCheck, Palace Resorts has implemented new systems to monitor, measure and manage resort operational efficiencies, adhering to the highest of scientific standards for sustainable tourism, including eco-friendly approaches to operations, conservation measures and Corporate Social Responsibility (CSR). As a result of fulfilling all new EarthCheck policies, Palace Resorts has also successfully completed the certifications for MARTI, the Meso American Reef Tourism Initiative, which awards companies that protect the region’s natural landscape through sustainable hotel operations. The Moon Palace Golf & Spa Resort and Riviera Cancun Golf & Resorts are the first in Latin America properties to be awarded the Golf Environment Organization (GEO) Certification, which boasts esteemed recognition and endorsement of the United Nations and the World Wildlife Foundation, as a result of the green design, construction, studies of impact, and environmental practices at these golf clubs and courses.www.palaceresorts.comlast_img read more

See More

You Are What You Eat 80 of Patient Advocacy Groups Take Money

first_imgShare124TweetShare6Email130 SharesPublic Domain. [CC 0]March 1, 2017; ReutersReaders may remember that even as legislators got incensed about a 400 percent increase in the price of EpiPens, patient advocacy groups were relatively silent. Instead of opposing the price hike, the groups kept busy in creating the market conditions that would allow such gouging. In fact, pharmaceutical companies seem to have made it a central part of their business plans to charge out-of-control prices and then fund groups to help to offset those prices with charitable give-back programs. These kinds of relationships can lead to other problems, of course, especially when the corporate funders are in leadership positions on the governing board, as we have previously described.Those following the emergence of this story will find no surprises in hearing that the norm for so-called patient advocacy organizations is close financial ties to companies involved in pharmaceuticals, biotechnology, and medical devices. The fact that taking such funding appears to be the dominant modus operandi in the field makes the serious conflict of interest issues raised by this all the more acute.An article yesterday in the New England Journal of Medicine reports on the findings of a study that investigated 104 of the largest of these nonprofit organizations. More than eight in ten get financial support from such corporations, more than a third have at least one industry representative on their governing body, and 12 percent have an industry official listed as leading the board.“Concerns have been raised that industry-supported patient-advocacy organizations have spoken out for access to drugs with questionable therapeutic benefit and remained silent on policy proposals, such as drug-pricing reforms, that might benefit their constituents,” writes the research team from the University of Pennsylvania in Philadelphia, who believe that the influence of the corporations is understated even in this study.What they did find, however, is nothing short of shocking. Many of the organizations, none of which has an annual budget under $7.5 million, are far less than transparent on their sources of revenue and board members. Still, around 40 percent of the groups studied received at least $1 million a year from these industries. Only 12 percent of the organizations posted conflict-of-interest policies on their websites.To cite one example of funding levels, the National Hemophilia Foundation reveals in its 2014 annual report that it received 50 percent to 83 percent of its annual revenue from drug or device companies.The foundation responded to Reuters Health with a statement saying that industry officials are prohibited from serving on its board and the organization “has never and will never advocate for any single treatment or group of treatments before legislators, or public and private payers. Instead, NHF advocates for all FDA-approved therapies, and will continue to fight to ensure that individuals with bleeding disorders have access to the therapies they need.”The American Diabetes Association, the Epilepsy Foundation, the Arthritis Foundation, the National Kidney Foundation, and the National Hemophilia Foundation each received at least 10 percent of their revenue from industry groups. However, those responding to Reuters’ inquiries said that donations don’t influence policy.For example, the Kidney Foundation, in a statement, said that although it does accept financial support from industry, “this support does not drive policy positions, priorities, mission or objectives” and the sole industry member on its 24-member board is prohibited from voting on matters related to that person’s business.The study’s authors recommend more transparency, and we suppose that is a start.Arthritis Foundation president Ann Palmer released a statement to Reuters Health, saying, “Our corporate partners pay to sponsor events and tools. To keep the needs of people with arthritis at the center of what we do, the Foundation makes advocacy and position decisions independently—our corporate partners do not shape our agenda or advocacy efforts.”Meanwhile, Democrats in Congress have stayed on the case. Earlier this month, they sent a letter to Kaléo Pharmaceuticals demanding to know why the price of their anti-opiate-overdose Naloxone injector had risen from $690 for a two-pack to $4500. Predictably, a new patient advocacy group, Patients for Affordable Drugs, is forming with the intention of providing a real voice to patients about such overpricing.—Ruth McCambridgeCorrection: This article has been altered from its original form to remove an organization that was erroneously listed among those who received 10 percent or more of their revenue from industry groups.Share124TweetShare6Email130 Shareslast_img read more

See More